Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2007. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1202876013 | Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
1478899010 | Alprostadil+alprostadil alfadex+lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder | Is a | Product containing alprostadil | false | Inferred relationship | Existential restriction modifier | ||
Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder | Is a | Product containing alprostadil in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder | Has active ingredient | Alprostadil | false | Inferred relationship | Existential restriction modifier | ||
Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder | Has active ingredient | Prostaglandin E>1< | false | Inferred relationship | Existential restriction modifier | ||
Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets